Found 87 results
Author [ Keyword(Desc)] Title Type Year
Filters: Author is Tripathy, Sasmita  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Acetyltransferases
Tripathy S, Torres-Gonzalez M, Jump DB.  2010.  Elevated hepatic fatty acid elongase-5 activity corrects dietary fat-induced hyperglycemia in obese C57BL/6J mice.. J Lipid Res. 51(9):2642-54.
Tripathy S, Lytle KA, Stevens RD, Bain JR, Newgard CB, Greenberg AS, Huang L-S, Jump DB.  2014.  Fatty acid elongase-5 (Elovl5) regulates hepatic triglyceride catabolism in obese C57BL/6J mice.. J Lipid Res. 55(7):1448-64.
Animal Feed
Depner CM, Torres-Gonzalez M, Tripathy S, Milne G, Jump DB.  2012.  Menhaden oil decreases high-fat diet-induced markers of hepatic damage, steatosis, inflammation, and fibrosis in obese Ldlr-/- mice.. J Nutr. 142(8):1495-503.
Animals
Jump DB, Depner CM, Tripathy S, Lytle KA.  2015.  Potential for dietary ω-3 fatty acids to prevent nonalcoholic fatty liver disease and reduce the risk of primary liver cancer.. Adv Nutr. 6(6):694-702.
Depner CM, Torres-Gonzalez M, Tripathy S, Milne G, Jump DB.  2012.  Menhaden oil decreases high-fat diet-induced markers of hepatic damage, steatosis, inflammation, and fibrosis in obese Ldlr-/- mice.. J Nutr. 142(8):1495-503.
Jump DB, Tripathy S, Depner CM.  2013.  Fatty acid-regulated transcription factors in the liver.. Annu Rev Nutr. 33:249-69.
Tripathy S, Lytle KA, Stevens RD, Bain JR, Newgard CB, Greenberg AS, Huang L-S, Jump DB.  2014.  Fatty acid elongase-5 (Elovl5) regulates hepatic triglyceride catabolism in obese C57BL/6J mice.. J Lipid Res. 55(7):1448-64.
Tripathy S, Torres-Gonzalez M, Jump DB.  2010.  Elevated hepatic fatty acid elongase-5 activity corrects dietary fat-induced hyperglycemia in obese C57BL/6J mice.. J Lipid Res. 51(9):2642-54.
Biomarkers
Depner CM, Torres-Gonzalez M, Tripathy S, Milne G, Jump DB.  2012.  Menhaden oil decreases high-fat diet-induced markers of hepatic damage, steatosis, inflammation, and fibrosis in obese Ldlr-/- mice.. J Nutr. 142(8):1495-503.
Blood Glucose
Tripathy S, Torres-Gonzalez M, Jump DB.  2010.  Elevated hepatic fatty acid elongase-5 activity corrects dietary fat-induced hyperglycemia in obese C57BL/6J mice.. J Lipid Res. 51(9):2642-54.
Cardiovascular Diseases
Jump DB, Depner CM, Tripathy S.  2012.  Omega-3 fatty acid supplementation and cardiovascular disease.. J Lipid Res. 53(12):2525-45.
Cholesterol
Tripathy S, Torres-Gonzalez M, Jump DB.  2010.  Elevated hepatic fatty acid elongase-5 activity corrects dietary fat-induced hyperglycemia in obese C57BL/6J mice.. J Lipid Res. 51(9):2642-54.
Cytokines
Depner CM, Torres-Gonzalez M, Tripathy S, Milne G, Jump DB.  2012.  Menhaden oil decreases high-fat diet-induced markers of hepatic damage, steatosis, inflammation, and fibrosis in obese Ldlr-/- mice.. J Nutr. 142(8):1495-503.
Diet
Tripathy S, Torres-Gonzalez M, Jump DB.  2010.  Elevated hepatic fatty acid elongase-5 activity corrects dietary fat-induced hyperglycemia in obese C57BL/6J mice.. J Lipid Res. 51(9):2642-54.
Diet, High-Fat
Jump DB, Tripathy S, Depner CM.  2013.  Fatty acid-regulated transcription factors in the liver.. Annu Rev Nutr. 33:249-69.
Diet, Western
Jump DB, Depner CM, Tripathy S, Lytle KA.  2015.  Potential for dietary ω-3 fatty acids to prevent nonalcoholic fatty liver disease and reduce the risk of primary liver cancer.. Adv Nutr. 6(6):694-702.
Dietary Fats
Depner CM, Torres-Gonzalez M, Tripathy S, Milne G, Jump DB.  2012.  Menhaden oil decreases high-fat diet-induced markers of hepatic damage, steatosis, inflammation, and fibrosis in obese Ldlr-/- mice.. J Nutr. 142(8):1495-503.
Tripathy S, Torres-Gonzalez M, Jump DB.  2010.  Elevated hepatic fatty acid elongase-5 activity corrects dietary fat-induced hyperglycemia in obese C57BL/6J mice.. J Lipid Res. 51(9):2642-54.
Dietary Fats, Unsaturated
Jump DB, Depner CM, Tripathy S, Lytle KA.  2015.  Potential for dietary ω-3 fatty acids to prevent nonalcoholic fatty liver disease and reduce the risk of primary liver cancer.. Adv Nutr. 6(6):694-702.
Dietary Supplements
Jump DB, Depner CM, Tripathy S.  2012.  Omega-3 fatty acid supplementation and cardiovascular disease.. J Lipid Res. 53(12):2525-45.
Disease Models, Animal
Jump DB, Depner CM, Tripathy S, Lytle KA.  2015.  Potential for dietary ω-3 fatty acids to prevent nonalcoholic fatty liver disease and reduce the risk of primary liver cancer.. Adv Nutr. 6(6):694-702.
Docosahexaenoic Acids
Jump DB, Depner CM, Tripathy S, Lytle KA.  2015.  Potential for dietary ω-3 fatty acids to prevent nonalcoholic fatty liver disease and reduce the risk of primary liver cancer.. Adv Nutr. 6(6):694-702.
Eicosapentaenoic Acid
Jump DB, Depner CM, Tripathy S, Lytle KA.  2015.  Potential for dietary ω-3 fatty acids to prevent nonalcoholic fatty liver disease and reduce the risk of primary liver cancer.. Adv Nutr. 6(6):694-702.
Endoplasmic Reticulum Stress
Tripathy S, Lytle KA, Stevens RD, Bain JR, Newgard CB, Greenberg AS, Huang L-S, Jump DB.  2014.  Fatty acid elongase-5 (Elovl5) regulates hepatic triglyceride catabolism in obese C57BL/6J mice.. J Lipid Res. 55(7):1448-64.
Fatty Acids
Tripathy S, Torres-Gonzalez M, Jump DB.  2010.  Elevated hepatic fatty acid elongase-5 activity corrects dietary fat-induced hyperglycemia in obese C57BL/6J mice.. J Lipid Res. 51(9):2642-54.

Pages